SLC6A1 and epilepsy: Defects in GAT-1 function have previously been associated with myoclonus, epilepsy (Johannesen et al., 2018) and altered GABAergic signaling (Jensen et al., 2003), unlike any of the other synaptic proteins we identified in our analyses.